MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

December 29, 2023

https://www.globenewswire.com/news-release/2023/12/29/2802179/0/en/MIMEDX-Provides-AXIOFILL-Update-Reiterates-2023-Full-Year-Net-Sales-and-Fourth-Quarter-Adjusted-EBITDA-Margin-Outlook.html

Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety

Request for Designation for AXIOFILL Submitted to FDA and Currently Under Review

Read more at globenewswire.com

Related news for (MDXG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.